Market Overview:
The global breast implant market size reached US$ 2.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.5 Billion by 2028, exhibiting a growth rate (CAGR) of 4.2% during 2023-2028.
Breast implants refer to a prosthesis device, which is formulated from the silicon outer shell that is stuffed with a blend of silicone gel and saline. This process is extensively deployed in cosmetic surgery for enhancing and changing the size, shape, and contour of the breast by replacing and removing tissue. Breast implants surgery includes anesthesia, incision, insertion, placement, and closing of the devices with layered sutures or surgical tape in the breast tissue. At present, the breast implant is commercially available in varying types, such as saline, silicone, structured, gummy bear, round, textured and smooth breast implants.
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Breast Implant Market Trends:
The increasing demand for breast implantation and cosmetic surgeries, along with the rising inclination of consumers toward maintaining an aesthetic appeal, is one of the key factors influencing the global breast implant market growth. Additionally, the escalating prevalence of breast cancer is fueling the market growth, as these implants are used in breast reconstruction procedures among patients. Moreover, the introduction of technologically advanced hyaluronic acid fillers and stable silicone gel breast implants for offering better resemblance to natural breast tissue is contributing to the market growth. In line with this, the widespread adoption of composite breasts is another growth-inducing factor. Furthermore, continual product launches and collaborations of various brands to sensitize the target audience about the post-surgery complications and associated risks is promoting the breast implant market growth. Various organizations are also forming partnership agreements for developing advanced breast implants using the 3D printing technology. Other factors, including rapid technological advancements, are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global breast implant market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, shape, application and end user.
Breakup by Product:
- Silicone Breast Implants
- Saline Breast Implants
Breakup by Shape:
Breakup by Application:
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Cosmetic Surgery
- Reconstructive Surgery
Breakup by End User:
- Hospitals
- Cosmetology Clinics
- Ambulatory Surgical Centers
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Allergan plc, CEREPLAS, Establishment Labs SA, Global Consolidated Aesthetics Limited, Groupe Sebbin SAS, HansBiomed Co. Ltd., Ideal Implant Inc., Laboratoires Arion, Mentor Worldwide LLC (Johnson & Johnson), POLYTECH Health & Aesthetics GmbH and Sientra Inc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2022 |
Historical Period |
2017-2022 |
Forecast Period |
2023-2028 |
Units |
US$ Billion |
Segment Coverage |
Product, Shape, Application, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Allergan plc, CEREPLAS, Establishment Labs SA, Global Consolidated Aesthetics Limited, Groupe Sebbin SAS, HansBiomed Co. Ltd., Ideal Implant Inc., Laboratoires Arion, Mentor Worldwide LLC (Johnson & Johnson), POLYTECH Health & Aesthetics GmbH and Sientra Inc. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |